mitoxantrone has been researched along with Chondrodysplasia with Hemangioma in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This report describes a patient with Ollier disease and AML and may offer a clue into the genetic pathogenesis of these disorders." | 1.35 | Acute myelogenous leukemia associated with Ollier disease. ( Martin, PL; McLean, TW; White, MS, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| White, MS | 1 |
| Martin, PL | 1 |
| McLean, TW | 1 |
1 other study available for mitoxantrone and Chondrodysplasia with Hemangioma
| Article | Year |
|---|---|
Acute myelogenous leukemia associated with Ollier disease.
Topics: Aminoglycosides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined | 2008 |